Bain Capital GSS issues going-concern warning
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Bain Capital GSS Investment Corp. (BCSS) is a blank-check company seeking an initial business combination; as of September 30, 2026, it had selected no target and held no substantive target discussions. It reported third-quarter net income of $4,205,920, comprising $4,450,065 of trust-account interest income less $244,145 of general and administrative expenses; it has generated no operating revenue. At September 30, trust-account deposits were $477,671,954, cash outside the trust was $622,015, and working capital was a $48,496 surplus.
Management said the company lacks liquidity to sustain operations for at least one year and that its liquidity condition and required liquidation if no combination occurs raise substantial doubt about its ability to continue as a going concern. The Sponsor or an affiliate may provide loans but is not obligated to do so. The Combination Period currently expires October 1, 2027; failure to complete a business combination within that period would require redemption of public shares and subsequent liquidation. Warrants receive no liquidation distribution and may expire worthless.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Positive
- None.
Negative
- Major pointGoing-concern doubt accompanies the October 1, 2027 current business-combination deadline.
Filing Explained
The Founder Share formula defines a future share amount equal to 20 percent of a specified base; warrant exercise could add shares after a combination.
At
Separately, 9.38 million warrants were outstanding; each whole warrant may be exercised for one Class A share at
Key Figures
Key Terms
going concern financial
Trust Account financial
temporary equity financial
Working Capital Loans financial
redeemable Public Warrant financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What was BCSS’s net income in the third quarter of 2026?
How much did BCSS hold in its Trust Account at September 30, 2026?
Why did BCSS report substantial doubt about its ability to continue as a going concern?
What condition could extend BCSS’s Combination Period beyond 24 months?
AI-generated analysis. How Rhea-AI works. Not financial advice.
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
| Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
| ☒ | Smaller reporting company | |||||
| Emerging growth company | ||||||
BAIN CAPITAL GSS INVESTMENT CORP.
FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2026
TABLE OF CONTENTS
| Page | ||||
| Part I. Financial Information |
1 | |||
| Item 1. Interim Financial Statements |
1 | |||
| Condensed Balance Sheets as of September 30, 2026 (Unaudited) and December 31, 2025 |
1 | |||
| Condensed Statements of Operations for the Three Months Ended September 30, 2026 and 2025, for the Nine Months Ended September 30, 2026 and for the Period from March 24, 2025 (Inception) through September 30, 2025 (Unaudited) |
2 | |||
| Condensed Statements of Changes in Shareholders’ Deficit for the Three Months Ended September 30, 2026 and 2025, for the Nine Months Ended September 30, 2026 and for the Period from March 24, 2025 (Inception) through September 30, 2025 (Unaudited) |
3 | |||
| Condensed Statements of Cash Flows for the Nine Months Ended September 30, 2026 and for the Period from March 24, 2025 (Inception) through September 30, 2025 (Unaudited) |
4 | |||
| Notes to Condensed Financial Statements (Unaudited) |
5 | |||
| Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations |
18 | |||
| Item 3. Quantitative and Qualitative Disclosures Regarding Market Risk |
20 | |||
| Item 4. Controls and Procedures |
21 | |||
| Part II. Other Information |
22 | |||
| Item 1. Legal Proceedings |
22 | |||
| Item 1A. Risk Factors |
22 | |||
| Item 2. Unregistered Sales of Equity Securities and Use of Proceeds |
22 | |||
| Item 3. Defaults Upon Senior Securities |
22 | |||
| Item 4. Mine Safety Disclosures |
22 | |||
| Item 5. Other Information |
22 | |||
| Item 6. Exhibits |
23 | |||
| Signatures |
24 | |||
September 30, 2026 |
December 31, 2025 |
|||||||
(Unaudited) |
||||||||
| Assets |
||||||||
| Current assets: |
||||||||
| Cash |
$ | $ | ||||||
| Prepaid expenses |
||||||||
| |
|
|
|
|||||
| Total current assets |
||||||||
| Long-term prepaid insurance |
||||||||
| Interest-bearing demand deposits held in Trust Account |
||||||||
| |
|
|
|
|||||
| Total Assets |
$ |
$ |
||||||
| |
|
|
|
|||||
| Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit |
||||||||
| Current liabilities: |
||||||||
| Accrued offering costs |
$ | $ | ||||||
| Accrued expenses |
||||||||
| Advances from related party |
||||||||
| |
|
|
|
|||||
| Total current liabilities |
||||||||
| Deferred underwriting fee |
||||||||
| |
|
|
|
|||||
| Total Liabilities |
||||||||
| |
|
|
|
|||||
| Commitments and Contingencies |
||||||||
| Class A ordinary shares subject to possible redemption, $ |
||||||||
| Shareholders’ Deficit: |
||||||||
| Preference shares, $ |
||||||||
| Class A ordinary shares, $ |
||||||||
| Class B ordinary shares, $ |
||||||||
| Additional paid-in capital |
||||||||
| Accumulated deficit |
( |
) | ( |
) | ||||
| |
|
|
|
|||||
| Total Shareholders’ Deficit |
( |
) |
( |
) | ||||
| |
|
|
|
|||||
| Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit |
$ |
$ |
||||||
| |
|
|
|
|||||
For the Three Months Ended September 30, |
For the Nine Months Ended September 30, |
For the Period from March 24, 2025 (Inception) Through September 30, |
||||||||||||||
2026 |
2025 |
2026 |
2025 |
|||||||||||||
| General and administrative expenses |
$ | $ | $ | $ | ||||||||||||
| |
|
|
|
|
|
|
|
|||||||||
| Loss from operations |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||
| |
|
|
|
|
|
|
|
|||||||||
| Other income: |
||||||||||||||||
| Interest earned on interest-bearing demand deposits held in Trust Account |
||||||||||||||||
| |
|
|
|
|
|
|
|
|||||||||
| Total other income |
||||||||||||||||
| |
|
|
|
|
|
|
|
|||||||||
| Net income (loss) |
$ |
$ |
( |
) |
$ |
$ |
( |
) | ||||||||
| |
|
|
|
|
|
|
|
|||||||||
| Basic and diluted weighted average Class A ordinary shares outstanding |
||||||||||||||||
| |
|
|
|
|
|
|
|
|||||||||
| Basic and diluted net income (loss) per Class A ordinary share |
$ |
$ |
$ |
$ |
||||||||||||
| |
|
|
|
|
|
|
|
|||||||||
| Basic and diluted weighted average Class B ordinary shares outstanding(1) |
||||||||||||||||
| |
|
|
|
|
|
|
|
|||||||||
| Basic and diluted net income (loss) per Class B ordinary share |
$ |
$ |
( |
) |
$ |
$ |
( |
) | ||||||||
| |
|
|
|
|
|
|
|
|||||||||
| (1) | Prior to the Initial Public Offering, |
Class A Ordinary Shares |
Class B Ordinary Shares |
Additional Paid-in Capital |
Accumulated Deficit |
Total Shareholders’ Deficit |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
| Balance — December 31, 2025 |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
| Accretion of carrying value to redemption value |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
| Net income |
— | — | — | — | — | |||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Balance — March 31, 2026 (unaudited) |
( |
) |
( |
) | ||||||||||||||||||||||||
| Accretion of carrying value to redemption value |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
| Net income |
— | — | — | — | — | |||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Balance — June 30, 2026 (unaudited) |
( |
) |
( |
) | ||||||||||||||||||||||||
| Accretion of carrying value to redemption value |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
| Net income |
— | — | — | — | — | |||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Balance — September 30, 2026 (unaudited) |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Class A Ordinary Shares |
Class B Ordinary Shares(1) |
Additional Paid-in Capital |
Accumulated Deficit |
Total Shareholders’ Equity (Deficit) |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
| Balance — March 24, 2025 (Inception) |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||||||
| Issuance of Class B ordinary shares to Sponsor |
— | — | — | |||||||||||||||||||||||||
| Net loss |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Balance — March 31, 2025 |
( |
) |
||||||||||||||||||||||||||
| Net loss |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Balance — June 30, 2025 |
( |
) |
( |
) | ||||||||||||||||||||||||
| Net loss |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Balance — September 30, 2025 |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| (1) | Included up to |
For the Nine Months Ended September 30, 2026 |
For the Periodfrom March 24, 2025 (Inception) Through September 30, 2025 |
|||||||
| Cash Flows from Operating Activities: |
||||||||
| Net income (loss) |
$ | $ | ( |
) | ||||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: |
||||||||
| Interest earned on interest-bearing demand deposits held in Trust Account |
( |
) | ||||||
| Payment of general and administrative expenses through promissory note – related party |
||||||||
| Payment of formation costs through issuance of Class B ordinary shares |
||||||||
| Changes in operating assets and liabilities: |
||||||||
| Prepaid expenses |
( |
) | ||||||
| Long-term prepaid insurance |
||||||||
| Accrued expenses |
||||||||
| |
|
|
|
|||||
| Net cash used in operating activities |
( |
) |
||||||
| |
|
|
|
|||||
| Cash Flows from Investing Activities: |
||||||||
| Investment of cash into Trust Account |
( |
) | ||||||
| |
|
|
|
|||||
| Net cash used in investing activities |
( |
) | ||||||
| |
|
|
|
|||||
| Cash Flows from Financing Activities: |
||||||||
| Advances from related party |
||||||||
| Payment of offering costs |
( |
) | ||||||
| |
|
|
|
|||||
| Net cash provided by financing activities |
||||||||
| |
|
|
|
|||||
| Net change in cash |
( |
) |
||||||
| Cash – beginning of the period |
||||||||
| |
|
|
|
|||||
| Cash – end of the period |
$ |
$ |
||||||
| |
|
|
|
|||||
| Supplemental disclosure of noncash investing and financing activities: |
||||||||
| Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares |
$ | $ | ||||||
| |
|
|
|
|||||
| Deferred offering costs paid through promissory note – related party |
$ | $ | ||||||
| |
|
|
|
|||||
| Deferred offering costs included in accrued offering costs |
$ | $ | ||||||
| |
|
|
|
|||||
| • | Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
| • | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
| • | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
| For the Three Months Ended September 30, |
For the Nine Months Ended September 30, |
For the Period from March 24, 2025 (Inception) Through September 30, |
||||||||||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||||||||||||
| Class A Ordinary Shares |
Class B Ordinary Shares |
Class A Ordinary Shares |
Class B Ordinary Shares |
Class A Ordinary Shares |
Class B Ordinary Shares |
Class A Ordinary Shares |
Class B Ordinary Shares |
|||||||||||||||||||||||||
Basic and diluted net income (loss) per ordinary share |
||||||||||||||||||||||||||||||||
Numerator: |
||||||||||||||||||||||||||||||||
Allocation of net income (loss) |
$ | $ | $ | $ | ( |
) | $ | $ | $ | $ | ( |
) | ||||||||||||||||||||
Denominator: |
||||||||||||||||||||||||||||||||
Basic and diluted weighted average ordinary shares outstanding |
||||||||||||||||||||||||||||||||
Basic and diluted net income (loss) per ordinary share |
$ | $ | $ | |
$ | ( |
) | $ | $ | $ | $ | ( |
) | |||||||||||||||||||
| October 1, 2025 | ||||
Underlying stock price |
$ | |||
Exercise price |
$ | |||
Volatility |
% | |||
Term (in years) |
||||
Risk-free rate |
% | |||
Market adjustment |
% | |||
Gross proceeds |
$ | |||
Less: |
||||
Proceeds allocated to Public Warrants |
( |
) | ||
Public Shares issuance costs |
( |
) | ||
Plus: |
||||
Accretion of carrying value to redemption value |
||||
Class A ordinary shares subject to possible redemption, December 31, 2025 |
$ |
|||
Plus: |
||||
Accretion of carrying value to redemption value |
||||
Class A ordinary shares subject to possible redemption, March 31, 2026 |
$ |
|||
Plus: |
||||
Accretion of carrying value to redemption value |
||||
Class A ordinary shares subject to possible redemption, June 30, 2026 |
$ |
|||
Plus: |
||||
Accretion of carrying value to redemption value |
||||
Class A ordinary shares subject to possible redemption, September 30, 2026 |
$ |
|||
| • | in whole and not in part; |
| • | at a price of $ |
| • | upon a minimum of 30 days’ prior written notice of redemption, which is referred to as the |
| • | if, and only if, the last reported sale price of the Class A ordinary shares equals or exceeds $ |
| September 30, 2026 (unaudited) |
December 31, 2025 |
|||||||
| Cash |
$ | $ | ||||||
| Interest-bearing demand deposits held in Trust Account |
$ | $ | ||||||
| For the Three Months Ended September 30, |
For the Nine Months Ended September 30, |
For the Period from March 24, 2025 (Inception) Through September 30, |
||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| General and administrative expenses |
$ | $ | $ | $ | ||||||||||||
| Interest earned on interest-bearing demand deposits held in Trust Account |
$ | $ | $ | $ | ||||||||||||
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to Bain Capital GSS Investment Corp. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to Bain Capital GSS Investment Sponsor LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
Special Note Regarding Forward-Looking Statements
This Quarterly Report includes “forward-looking statements” that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Quarterly Report including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s Annual Report on Form 10-K for the period ended December 31, 2025, filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 20, 2026. The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
Overview
We are a blank check company incorporated on March 24, 2025 as a Cayman Islands exempted company formed for the purpose of effectuating an initial business combination. We intend to effectuate our initial business combination using cash from the proceeds of the initial public offering and the private placement of the Private Placement Units (as defined below), the proceeds of the sale of our shares in connection with our initial business combination (pursuant to forward purchase agreements or backstop agreements we may enter into following the consummation of the Initial Public Offering or otherwise), shares issued to the owners of the target, debt issued to bank or other lenders or the owners of the target, or a combination of the foregoing.
On October 1, 2025, we consummated our initial public offering of 46,000,000 units, which included the full exercise by the underwriter of its over-allotment option in the amount of 6,000,000 units, at $10.00 per unit, generating gross proceeds of $460,000,000. Simultaneously with the closing of the initial public offering, we consummated the sale of 900,000 Private Placement Units, at a price of $10.00 per Private Placement Unit, in a private placement to the sponsor, generating gross proceeds of $9,000,000.
We incurred transaction costs amounting to $23,835,700, consisting of $7,000,000 of cash underwriting fee (net of $1,000,000 underwriters’ reimbursement), $16,100,000 of deferred underwriting fee, and $735,700 of other offering costs.
Upon the closing of the initial public offering and the Private Placement, approximately $460.0 million ($10.00 per unit) of the net proceeds of the initial public offering and certain of the proceeds of the Private Placement were placed in a Trust Account, located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and may be held in cash, including in demand deposit accounts at a bank, or invested only in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invests only in direct U.S. government treasury obligations, as determined by us, until the earlier of: (i) the completion of a business combination and (ii) the distribution of the Trust Account as described below.
Our management has broad discretion with respect to the specific application of the net proceeds of the initial public offering and the sale of private placement units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that we will be able to complete a Business Combination successfully.
18
We must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time of the signing of the agreement to enter into the initial Business Combination. However, we will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the prospective partner company or otherwise acquires a controlling interest in the prospective partner company sufficient for it not to be required to register as an investment company under the Investment Company Act.
If we are unable to complete a Business Combination within the Combination Period, we will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to us to pay our income taxes, if any (less up to $100,000 of interest to pay dissolution expenses) divided by the number of the then-outstanding Public Shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii), to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to our warrants, which will expire worthless if we fail to consummate a Business Combination within the Combination Period.
As of September 30, 2026, we held cash of $622,015, cash held in Trust Account of $477,671,954, and current liabilities of $820,069. Further, we expect to continue to incur significant costs in the pursuit of our initial business combination. We cannot assure you that our plans to complete an initial business combination will be successful.
Results of Operations
We have neither engaged in any operations nor generated any operating revenues to date. Our only activities from March 24, 2025 (inception) through September 30, 2026 were organizational activities and identifying and evaluating a target company for a business combination. We do not expect to generate any operating revenues until after the completion of our initial business combination. We will generate non-operating income in the form of interest and dividend income on cash and investments held after the Initial Public Offering. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence.
For the three months ended September 30, 2026 we had a net income of $4,205,920 which consists of interest earned on interest-bearing demand deposits held in Trust Account of $4,450,065, offset by general and administrative costs of $244,145.
For the three months ended September 30, 2025, we had a net loss of $20,600, which consists of general and administrative costs.
For the nine months ended September 30, 2026 we had a net income of $12,171,565 which consists of interest earned on interest-bearing demand deposits held in Trust Account of $13,023,871, offset by general and administrative costs of $852,306.
For the period from March 24, 2025 (inception) through September 30, 2025, we had a net loss of $71,168, which consists of general and administrative costs.
Liquidity and Capital Resources
Until the consummation of the initial public offering, our only source of liquidity was an initial purchase of shares of Class B ordinary shares, par value $0.0001 per share (the “Founder Shares”), by the Sponsor, and loans from the Sponsor, which were repaid at the closing of the initial public offering. As of September 30, 2026, we had $622,015 in cash and working capital surplus of $48,496.
On October 1, 2025, we consummated the Initial Public Offering of 46,000,000 Units, which includes the full exercise by the underwriters of their over-allotment option in the amount of 6,000,000 Units, at $10.00 per Unit, generating gross proceeds of $460,000,000. Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 900,000 Private Placement Units, at a price of $10.00 per Private Placement Unit, in a private placement to the Sponsor, generating gross proceeds of $9,000,000.
Following closing of the initial public offering, and the sale of the Private Placement Units, a total of $460,000,000 was placed in the Trust Account. We incurred transaction costs amounting to $23,835,700, consisting of $7,000,000 of cash underwriting fee (net of $1,000,000 underwriters’ reimbursement), $16,100,000 of deferred underwriting fee, and $735,700 of other offering costs.
For the nine months ended September 30, 2026, net cash used in operating activities was $290,791. Net income of $12,171,565 was offset by interest earned from the interest-bearing demand deposit account of $13,023,871 and changes in operating assets and liabilities, which provided $561,515 of cash from operating activities.
For the period from March 24, 2025 (inception) through September 30, 2025, net cash used in operating activities was $0. Net loss of $71,168 was offset by payment of general and administrative costs through promissory note – related party of $40,380, payment of formation costs through issuance of Class B ordinary shares of $10,188, and changes in operating assets and liabilities, which provided $20,600 of cash from operating activities.
19
As of September 30, 2026, we had $477,671,954 held in the Trust Account in an interest-bearing demand deposit account. Funds held in the Trust Account may be held in cash, including in demand deposit accounts at a bank, or invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. We may withdraw interest from the Trust Account to pay taxes, if any. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less income taxes payable), to complete our Business Combination. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.
As of September 30, 2026, we had cash of $622,015. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.
In order to fund working capital deficiencies or finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete our initial business combination, we may repay such loaned amounts. In the event that our initial business combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into units of the post-business combination company at a price of $10.00 per unit at the option of the lender. The units would be identical to the Private Placement Units. The terms of such loans, if any, have not been determined and no written agreements exist with respect to such loans. Prior to the completion of our initial business combination, we do not expect to seek loans from parties other than our sponsor, members of our management team or any of their affiliates as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our Trust Account.
In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Codification (“ASC”) 205-40, “Presentation of Financial Statements—Going Concern,” management has determined that the Company currently lacks the liquidity it needs to sustain operations for a reasonable period of time, which is considered to be at least one year from the date that the unaudited condensed financial statements are issued as it expects to continue to incur significant costs in pursuit of its acquisition plans. Management plans to address this uncertainty through a Business Combination. There is no assurance that the Company’s plans to raise capital or to consummate a Business Combination will be successful within the Combination Period. In addition, if a Business Combination is not consummated by October 1, 2027, there will be mandatory liquidation and subsequent dissolution of the Company. The Company’s liquidity condition and the mandatory liquidation and subsequent dissolution raise substantial doubt about the Company’s ability to continue as a going concern.
Off-Balance Sheet Arrangements
We did not have any off-balance sheet arrangements as of September 30, 2026.
Contractual Obligations
We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to pay the Sponsor $20,000 per month for office space, secretarial and administrative services.
The underwriters were paid a cash underwriting discount of $0.20 per Unit, or $8,000,000 in the aggregate, upon the closing of the Initial Public Offering excluding the units issued pursuant to the full exercise of the over-allotment option. The underwriters paid the Company an aggregate amount of $1,000,000 at the closing of the Initial Public Offering as reimbursement to the Company for certain of its expenses and fees incurred in connection with the Initial Public Offering. In addition, $0.35 per unit, or $16,100,000 in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that we complete a Business Combination, subject to the terms of the underwriting agreement.
Critical Accounting Policies
The preparation of condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could materially differ from those estimates. As of September 30, 2026, we have identified the valuation of Founder Shares that will be issued in relation to the consummation of a Business Combination as a critical accounting estimate.
Item 3. Quantitative and Qualitative Disclosures Regarding Market Risk
This item is not applicable as we are a smaller reporting company.
20
Item 4. Controls and Procedures
Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under Securities Exchange Act of 1934, as amended (the “Exchange Act”) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.
Evaluation of Disclosure Controls and Procedures
As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2026. Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) were effective.
Management Report on Internal Controls Over Financial Reporting
This Quarterly Report does not include a report of management’s assessment regarding internal control over financial reporting or an attestation report of our independent registered public accounting firm due to a transition period established by rules of the SEC for newly public companies.
Changes in Internal Control Over Financial Reporting
During the most recently completed fiscal quarter, there has been no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
21
Item 6. Exhibits
The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.
| No. | Description of Exhibit | |
| 31.1* | Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
| 31.2* | Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
| 32.1* | Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
| 32.2* | Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
| 101.INS* | XBRL Instance Document | |
| 101.SCH* | XBRL Taxonomy Extension Schema Document | |
| 101.CAL* | XBRL Taxonomy Extension Calculation Link base Document | |
| 101.DEF* | XBRL Taxonomy Extension Definition link base Document | |
| 101.LAB* | XBRL Taxonomy Extension Labels linkable Document | |
| 101.PRE* | XBRL Taxonomy Extension Presentation Link base Document | |
| * | Filed herewith (or furnished herewith in the case of exhibits 32.1 and 32.2). |
23
SIGNATURES
In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| BAIN CAPITAL GSS INVESTMENT CORP. | ||||||
| Date: November 13, 2026 | By: | /s/ Angelo Rufino | ||||
| Name: | Angelo Rufino | |||||
| Title: | Chief Executive Officer (Principal Executive Officer) | |||||
| Date: November 13, 2026 | By: | /s/ Patrick Dury | ||||
| Name: | Patrick Dury | |||||
| Title: | Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) | |||||
24